NEW YORK (Reuters Health) – In middle-aged Chinese adults, hyperuricemia is an independent risk factor for all-cause mortality, cardiovascular disease, and ischemic stroke, according to results of prospective…
NEW YORK (Reuters Health) – Based on preliminary results in two patients with severe rheumatoid arthritis, intraarticular delivery of a gene encoding a cytokine blocker substantially reduces joint…
About 15 minutes of vibration produces similar results to an hour of conventional resistance therapy, and produces less stress on joints, ligaments and tendons. ~ Detroit Medical Center…
NEW YORK (Reuters Health) – As treatments for rheumatoid arthritis, rituximab and abatacept do not increase the risk of serious infections, a meta-analysis of trial data suggests. High…
As part of the Johnston County Osteoarthritis Project, Dr. Joanne Jordan, director of the University of North Carolina Thurston Arthritis Research Center, and colleagues have found that African…
Chad Deal, MD, Rheumatologist, Head, Center for Osteoporosis and Metabolic Bone Disease, Cleveland Clinic, discusses a new antiresorptive agent for osteoporosis, denosumab, a fully human monoclonal antibody that…
By Megan Rauscher NEW YORK (Reuters Health) – Results of an MRI study suggest that the brain may be affected very early in the course of systemic lupus…
NEW YORK (Reuters Health) – Results of a case-control study suggest that psoriatic arthritis patients may have “subtle” cardiac conduction disturbances. “In surveying the literature, scant data were…
NEW YORK (Reuters Health) – Sustained clinical improvements in signs and symptoms of rheumatoid arthritis are apparent within one week of initiating treatment with a novel pegylated TNF…